ID
20385
Description
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 10 (Month 42) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Keywords
Versions (1)
- 2/21/17 2/21/17 -
Uploaded on
February 21, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Trial Medication Compliance Discontinuation Dispense Visit 10 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Trial Medication Compliance Discontinuation Dispense Visit 10 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Description
Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Description
Discontinuation Of Trial Medication
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0457454
Description
If the patient permanently discontinued one or more of the trial medications since the previous visit, please record detailed information on the Permanent Termination of Trial Medication page 48. Even if the patient has stopped all trial medication he/she should be encouraged to return for all remaining visits.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0205355
Description
5. Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Description
Adverse Event Led to Discontinuation
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0457454
Description
Drug
Data type
integer
Alias
- UMLS CUI [1]
- C0013227
Description
Date Stopped
Data type
date
Alias
- UMLS CUI [1]
- C1531784
Description
Date Restarted
Data type
date
Alias
- UMLS CUI [1]
- C3173309
Description
Trial Medication due to an Adverse Event
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1531784
Description
if Yes
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Dispense Trail Medication
Alias
- UMLS CUI-1
- C0947323
Description
Preparation for next visit
Alias
- UMLS CUI-1
- C1521827
- UMLS CUI-2
- C0545082
Description
Signature
Data type
text
Alias
- UMLS CUI [1]
- C1519316
Description
Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1519316
Similar models
Trial Medication Compliance Discontinuation Dispense Visit 10 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0013227 (UMLS CUI-2)
C0457432 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C1531784 (UMLS CUI [1,2])
C0545082 (UMLS CUI-2)
C1519316 (UMLS CUI [1,2])